One blood test could screen you for 50 cancers. Here’s why it’s controversial.
A Food and Drug Administration committee backed a cancer blood test called Galleri but was split on how well it works.
The test is awaiting a final decision by the FDA.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.washingtonpost.com — the content belongs to The Washington Post.
